Journal of Applied Physiology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 104: 559-560, 2008. First published July 5, 2007; doi:10.1152/japplphysiol.00694.2007
8750-7587/08 $8.00
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
104/2/559    most recent
00694.2007v1
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andreassen, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andreassen, A. K.

POINT-COUNTERPOINT

Point:Counterpoint: Cardiac denervation does/does not play a major role in exercise limitation after heart transplantation

Arne K. Andreassen

Department of Cardiology
Rikshospitalet-Radiumhospitalet Medical Center
University of Oslo
Oslo, Norvay
e-mail: aren.andreassen{at}rikshospitalet.no

POINT: CARDIAC DENERVATION DOES PLAY A MAJOR ROLE IN EXERCISE LIMITATION AFTER HEART TRANSPLANTATION

With more than 100,000 procedures performed worldwide, more than 50% of patients undergoing orthotopic heart transplantation (HTx) survive longer than 10 years and enjoy significant and lasting improvements in their quality of life. However, exercise capacity by objective exercise testing has been shown to be markedly reduced. Despite normal ventricular ejection fraction at rest and a peak oxygen consumption that is higher than compared with preoperative values, exercise performance is typically only 40–60% of age-, sex-, and weight-matched controls. This phenomenon is best explained by the consequences of cardiac denervation at the time of explantation of a donor heart with subsequent HTx.

In nontransplanted subjects, the capacity for performing aerobic exercise depends on the ability of the heart to augment its output to exercising muscles and the ability of these muscles to use oxygen from the delivered blood. The increase in cardiac output (typically 4- to 6-fold) is caused by tachycardia operating in concert with increased myocardial contractility (20–50% augmentation of stroke volume) brought about by the greater sympathetic activity, together with the Frank-Starling mechanism (1). The autonomic nervous system plays a key role in the regulation of heart rate. The initial rise in heart rate is due to withdrawal of vagal tone, resulting in an increase of 30–50 beats/min. Thereafter, increments are attributed to an increase in activity to cardiac sympathetic nerves (20).

HTx recipients modulate their cardiac output in response to exercise in a different manner than in the normal heart, with no direct parasympathetic or sympathetic innervation. Due to lack of efferent vagal control, resting heart rate is elevated and with limited ability to increase heart rate early in exercise. Thus initial increases in cardiac output are completely dependent on augmented stroke volume (18). Increases in heart rate during later phases of exercise rely on an increase in circulating catecholamines because of sympathetic denervation (18). Importantly, the expected maximal inotropic left ventricular stimulation may also suffer from denervation due to at least two mechanisms. First, intact sympathetic nerve terminals with local norepinephrine release are required for maximum ventricular inotropic stimulation (20). Second, according to the frequency-force relationship, the time interval between beats is a determinant of the force of myocardial contraction. While the background for this last phenomenon is uncertain, it has been linked with calcium availability to contractile elements (4).

Several reports have demonstrated an association between subnormal exercise capacity and chronotropic incompetence in the form of reductions in the rate of rise in heart rate, increase in heart rate, and peak exercise heart rate (2, 5, 810, 14, 15, 19, 21, 22, 26). The largest studies have also shown that heart rate is a powerful and independent predictor of exercise capacity (8, 9, 14). Assessing maximal symptom-limited graded upright bicycle testing with simultaneous invasive hemodynamic monitoring, Kao et al. (10) described the consequences of a 30% lower heart rate response and 79% lower heart rate reserve in 30 HTx recipients compared with healthy controls. The lower stroke and cardiac index throughout exercise, coupled with inability to compensate with the Starling mechanism, resulted in 43% lower peak weight-adjusted oxygen consumption than in controls. The authors conclude that the chronotropic incompetence "is no doubt a result of the effects of denervation" and a major limiting factor to exercise capacity. The lack of direct innervation of the sinoatrial node as the cause for the attenuated response to peak heart rate to exercise in HTx is strongly supported by the observations that the rise in circulating catecholamines is normal or increased at peak exercise, and the responsiveness of the sinoatrial node to beta-adrenergic stimulation is also normal or increased (7, 23).

Serial assessment of exercise capacity in HTx recipients demonstrates some improvement in heart rate and peak VO2 during the first postoperative year (9). Nevertheless, they remain less fit at 1 year also compared with patients undergoing coronary artery bypass graft surgery (23). Interestingly, when extending comparisons to renal transplant recipients without denervated hearts, a near-normal exercise capacity is reached within a few months after surgery (6). The latter observation shows that contrary to speculations, the use of standard immunosuppressive medication does not necessarily relate to below-normal exercise capacity. Furthermore, while regular exercise and rehabilitation can improve peak VO2 and workload in various patient groups, improvements in heart rate reserve and peak heart rate in HTx recipients are either modest or negligible. In the mentioned comparison with bypass-treated patients, heart rate reserve was unchanged among HTx recipients while it increased significantly in the former group (16). In the only controlled trial of postoperative rehabilitation after HTx, Kobashigawa et al. (13) demonstrated a 2.5 ml·kg–1·min–1 higher increase in peak VO2 after 6 mo in the exercise group than in the nonexercising group without any difference in improvement of peak heart rate at the end of the study. Thus, whereas exercise training within the first year after HTx modestly increases the capacity for physical work compared with a more sedentary daily life, this must either be due to a physiological training effect such as improved muscle-skeletal weakness or merely an ability to exercise with greater effort.

Although conflicting results have been obtained, some studies describe the abnormal chronotropic response to exercise initially after HTx to return toward normal after 1–2 yr, suggesting sympathetic reinnervation (9, 21). Conclusively observed in animals (12), reinnervation in humans has also been inferred from invasive measurements of transcardiac epinephrine spillover (26), noninvasive imaging with radiolabeled catecholamine analogs (24), and by heart rate variability analyses (11), supported by observations such as typical anginal pain in those with graft vasculopathy (25) and regrowth of nerves across the aortic anastomosis determined by microscopy (17). Taken together, experimental and clinical evidence suggests that some degree of sympathetic reinnervation takes place over time at the sinus and the ventricular level, but not in all patients.

Is there a correlation between documented graft reinnervation and physiological improvements in response to exercise, underlining the major role of an intact autonomous nervous system during strenuous activity? Indeed, two studies report improved functional parameters of exercise testing. Evaluated up to 13.4 yr postoperatively, positron emission tomographic (PET) evidence of reinnervation was found in 80% of patients more than 3 yr after HTx, with better peak VO2 values than those without signs of reinnervation (27). Bengel et al. (3) added radionuclide angiography to PET examinations and demonstrated sympathetic reinnervation mainly in the anteroseptal wall in 16 of 29 patients with a mean follow-up of 3.2 yr after HTx. Reinnervated patients had a significantly longer exercise time and higher peak heart rate compared with those with denervation. Furthermore, the contractile response to exercise was significantly enhanced in the former group. Although workload and maximal heart rate reached levels that did not differ significantly from controls in this study, reinnervation is incomplete and with a broad individual spread, perhaps explaining why not all follow-up studies are able to pick up improvements in heart rate and peak VO2 over time (8).

In summary, the persistent impairment in exercise capacity after HTx relates strongly to a combination of chronotropic and inotropic incompetence, both consequences of cardiac denervation. Evidence of late partial reinnervation in some patients, coupled with improved physical capacity, underlines the importance of an intact functioning autonomic nervous system to maintain a normal circulatory response to exercise also in HTx recipients.

REFERENCES

  1. Hammond HK, Froelicher VF. Normal and abnormal heart rate responses to exercise. Prog Cardiovasc Dis 27: 271–296, 1985.[CrossRef][Web of Science][Medline]
  2. Banner NB, Patel N, Cox AP, Patton HE, Lachino DR, Yacoub MH. Altered sympathoadrenal response to dynamic exercise in cardiac transplant recipients. Cardiovasc Res 23: 965–972, 1989.[Abstract/Free Full Text]
  3. Bengel FM, Ueberfuhr P, Schiepel N, Nekolla SG, Reichart B, Schwaiger M. Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans. N Engl J Med 345: 731–738, 2001.[Abstract/Free Full Text]
  4. Blinks JR, Koch-Weser J. Analysis of the effects of changes in rate and rhythm upon myocardial contractility. J Pharmacol Exp Ther 134: 373–389, 1976.
  5. Christos SC, Katch V, Crowley DC, Eakin BL, Linauer AL, Beekman RH. Hemodynamic responses to upright exercise of adolescent cardiac transplant recipients. J Pediatr 121: 312–316, 1992.[CrossRef][Medline]
  6. Daida H, Gau GT. Sequential assessment of exercise tolerance in heart transplantation compared with coronary bypass surgery after phase II cardiac rehabilitation. Am J Cardiol 77: 696–670, 1996.[CrossRef]
  7. Degre SG, Niset GL, De Smet JM, Ibrahim T, Stoupel E, Le Clerc JL, Primo G. Cardiorespiratory response to early exercise testing after orthotopic cardiac transplantation. Am J Cardiol 60: 926–928, 1987.[CrossRef][Web of Science][Medline]
  8. Givertz MM, Hartley LH, Colucci WS. Long-term sequential changes in exercise capacity and chronotropic responsiveness after cardiac transplantation. Circulation 96: 232–237, 1997.[Abstract/Free Full Text]
  9. Gullestad L, Haywood G, Ross H, Bjørnerheim R, Geiran O, Kjekshus J, Simonsen S, Fowler M. Exercise capacity of heart transplant recipients: The importance of chronotropic incompetence. J Heart Lung Transplant 15: 1075–1083, 1996.[Web of Science][Medline]
  10. Kao AC, Van Trigt P, Shaeffer-McCall GS, Shaw JP, Kuzil BB, Page RD, Higginbottam MB. Central and peripheral limitations to upright exercise in untrained cardiac transplant recipients. Circulation 89: 2605–2615, 1994.[Abstract/Free Full Text]
  11. Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, Jennings G. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation 88: 1110–1118, 1993.[Abstract/Free Full Text]
  12. Kaye MP, Esler M. Chronology and mode of reinnervation of the surgically denervated canine heart: functional and chemical correlates. Am J Physiol 2: H431–H437, 1977.
  13. Kobashigawa JA, Leaf DA, Lee N, Gleeson MP, Liu H, Hamilton MA, Moriguchi JD, Kawata N, Einhorn K, Herlihy E, Laks H. A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med 340: 272–277, 1999.[Abstract/Free Full Text]
  14. Leung TC, Ballman KV, Allison TG, Wagner JA, Olson LJ, Frantz RP, Edwards BS, Dearani JA, Daly RC, McGregor CG, Rodeheffer RJ. Clinical predictors of exercise capacity 1 year after cardiac transplantation. J Heart Lung Transplant 22: 16–27, 2003.[CrossRef][Medline]
  15. Mandak JS, Aaronsen KD, Mancini DM. Serial assessment of exercise capacity after heart transplantation. J Heart Lung Transplant 14: 468–478, 1995.[Web of Science][Medline]
  16. Miller TD, Squires RW, Gau GT, Ilstrup DM, Frohnert PP, Sterioff S. Graded exercise testing and training after renal transplantation: a preliminary study. Mayo Clin Proc 62: 773–777, 1987.[Medline]
  17. Norvell JE, Lower RR. Degeneration and reinnervation of the nerves of the heart after transplantation. Transplantation 15: 337–344, 1973.[CrossRef][Medline]
  18. Pope SE, Stinson EB, Daughters GT, Schroeder JS, Ingels J, Alderman EL. Exercise response of the denervated heart in long term cardiac transplant recipients. Am J Cardiol 46: 213–218, 1980.[CrossRef][Web of Science][Medline]
  19. Quigg RJ, Rocco MB, Gauthier DF, Creager MA, Hartley LH, Colucci WS. Mechanism of the attenuated peak heart rate response to exercise after orthotopic cardiac transplantation. J Am Coll Cardiol 14: 338–344, 1989.[Abstract]
  20. Robinson BF, Epstein SE, Beiser GD, Braunwald E. Control of heart rate by the autonomic nervous system: Studies in man on the interelation between baroreceptor mechanisms and exercise. Circ Res 28: 400–411, 1966.
  21. Rudas L, Pflugfelder PW, Menkis AH, Novick RJ, McKenzie FN, Kostuk WJ. Evolution of heart rate responsiveness after orthotopic cardiac transplantation. Am J Cardiol 68: 232–236, 1991.[CrossRef][Medline]
  22. Savin WM, Haskell WL, Schroeder JS, Stinson EB. Cardiorespiratory responses of cardiac transplant patients to graded, symptom-limited exercise. Circulation 62: 55–60, 1980.[Abstract/Free Full Text]
  23. Schuler S, Thomas D, Thebken M. Endocrine response to exercise in cardiac transplant patients. Transplant Proc 19: 2506–2509, 1987.[Medline]
  24. Schwaiger H, Hutchins GD, Kalff V, Rosenspire K, Haka MS, Mallette S, Deeb GM, Abrams GD, Wieland D. Evidence for regional catecholamine uptake and storage sites in the transplanted heart by positron emission tomography. J Clin Invest 87: 1681–1690, 1991.[Web of Science][Medline]
  25. Stark RP, McGinn AL, Wilson RF. Chest pain in cardiac-transplant recipients: evidence of sensory reinnervation after cardiac transplantation. N Engl J Med 324: 1791–1794, 1991.[Web of Science][Medline]
  26. Stevenson LW, Sietsema K, Tillisch JH, Lem V, Walden J, Kobashigawa JA, Moriguchi. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation 81: 78–85, 1990.[Abstract/Free Full Text]
  27. Ueberfuhr P, Ziegler S, Schwaiblmair M, Reichart B, Schwaiger M. Incomplete sympathetic reinnervation of the orthotopically transplanted human heart: observation up to 13 years after heart transplantation. Eur J Cardiothorac Surg 17: 161–168, 2000.[Abstract/Free Full Text]
  28. Wilson RF, Laxson DD, Christensen BV, McGinn AL, Kubo SH. Regional differences in sympathetic reinnervation after human orthotopic cardiac transplantation. Circulation 88: 165–171, 1993.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
104/2/559    most recent
00694.2007v1
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andreassen, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andreassen, A. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.